KYRIXMA Trademark

Trademark Overview


On Monday, August 2, 2021, a trademark application was filed for KYRIXMA with the United States Patent and Trademark Office. The USPTO has given the KYRIXMA trademark a serial number of 79319590. The federal status of this trademark filing is REGISTERED as of Tuesday, February 15, 2022. This trademark is owned by NOVARTIS AG. The KYRIXMA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
kyrixma

General Information


Serial Number79319590
Word MarkKYRIXMA
Filing DateMonday, August 2, 2021
Status700 - REGISTERED
Status DateTuesday, February 15, 2022
Registration Number6641719
Registration DateTuesday, February 15, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 30, 2021

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 13, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Monday, July 4, 2022NOTIFICATION PROCESSED BY IB
Saturday, June 4, 2022FINAL DISPOSITION NOTICE SENT TO IB
Friday, June 3, 2022FINAL DISPOSITION PROCESSED
Thursday, March 17, 2022GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, February 15, 2022REGISTERED-PRINCIPAL REGISTER
Sunday, December 12, 2021NOTIFICATION PROCESSED BY IB
Tuesday, November 30, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 30, 2021PUBLISHED FOR OPPOSITION
Wednesday, November 17, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 17, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 8, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, November 8, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 8, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, November 8, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 8, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 8, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 26, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 19, 2021ASSIGNED TO EXAMINER
Friday, September 17, 2021APPLICATION FILING RECEIPT MAILED
Monday, September 13, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 9, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, September 2, 2021SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB